Cystatin B as an intracellular modulator of bone resorption

Matrix Biology

Volumn 25, Issue 3, 2006, Pages 149-157

  Laitala Leinonen, Tiina ^a   Rinne, Riitta ^a   Saukko, Pekka ^a   Väänänen, H Kalervo ^a   Rinne, Ari ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Cathepsin K; Cystatin B; Osteoclast; Proteinase inhibitor; Resorption

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CATHEPSIN K; CYSTATIN B; CYSTEINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MEMBRANE; CELL VIABILITY; COW; CYTOSKELETON; DOSE RESPONSE; ENZYME ACTIVITY; IMMUNOHISTOLOGY; METAPHYSIS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BONE RESORPTION; CATHEPSINS; CATTLE; CELL SURVIVAL; CELLS, CULTURED; CYSTATINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETON; HUMANS; OSTEOCLASTS; RATS;

ANIMALIA; BOVINAE;

EID: 33645389709     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2005.10.005     Document Type: Article

References (67)

1. M. Abrahamson, M. Alvarez-Fernandez, and C.M. Nathanson Cystatins Biochem. Soc. Symp. 70 2003 179 199
2. K. Alakurtti, E. Weber, R. Rinne, G. Theil, G.J. de Haan, D. Lindhout, P. Salmikangas, P. Saukko, U. Lahtinen, and A.E. Lehesjoki Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations Eur. J. Hum. Genet. 13 2005 208 215
3. H.C. Blair, S.L. Teitelbaum, R. Ghiselli, and S. Gluck Osteoclastic bone resorption by a polarized vacuolar proton pump Science 245 1989 855 857
4. H.C. Blair, R.F. Sidonio, R.C. Friedberg, N.N. Khan, and S.S. Dong Proteinase expression during differentiation of human osteoclasts in vitro J. Cell Biochem. 78 2000 627 637
5. L. Blavier, and J.M. Delaisse Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones J. Cell Sci. 108 1995 3649 3659
6. M. Brage, M. Abrahamson, V. Lindstrom, A. Grubb, and U.H. Lerner Different cysteine proteinases involved in bone resorption and osteoclast formation Calcif. Tissue Int. 76 2005 439 447
7. M. Brage, A. Lie, M. Ransjö, F. Kasprzykowski, R. Kasprzykowska, M. Abrahamson, A. Grubb, and U.H. Lerner Osteoclastogenesis is decreased by cysteine proteinase inhibitors Bone 34 2004 412 424
8. D. Brömme, K. Okamoto, B.B. Wang, and S. Biroc Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme J. Biol. Chem. 271 1996 2126 2132
9. T.J. Chambers, and K. Fuller Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact J. Cell Sci. 76 1985 155 165
10. E. D'Amato, Z. Kokaia, A. Nanobashvili, M. Reeben, A.E. Lehesjoki, M. Saarma, and O. Lindvall Seizures induce widespread upregulation of cystatin B, the gene mutated in progressive myoclonus epilepsy, in rat forebrain neurons Eur. J. Neurosci. 12 2000 1687 1695
11. J.M. Delaisse, T.L. Andersen, M.T. Engsig, K. Henriksen, T. Troen, and L. Blavier Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities Microsc. Res. Tech. 61 2003 504 513
12. F.H. Drake, R.A. Dodds, I.E. James, J.R. Connor, C. Debouck, S. Richardson, E. Lee-Rykaczewski, L. Coleman, D. Rieman, R. Barthlow, G. Hastings, and M. Gowen Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts J. Biol. Chem. 271 1996 12511 12516
13. M.T. Engsig, Q.J. Chen, T.H. Vu, A.C. Pedersen, B. Therkidsen, L.R. Lund, K. Henriksen, T. Lenhard, N.T. Foged, Z. Werb, and J.M. Delaisse Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones J. Cell Biol. 151 2000 879 889
14. V. Everts, W. Korper, D.C. Jansen, J. Steinfort, I. Lammerse, S. Heera, A.J. Docherty, and W. Beertsen Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone FASEB J. 13 1999 1219 1230
15. L. Filgueira Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols J. Histochem. Cytochem. 52 2004 411 414
16. P. Garnero, O. Borel, I. Byrjalsen, M. Ferreras, F.H. Drake, M.S. McQueney, N.T. Foged, P.D. Delmas, and J.M. Delaisse The collagenolytic activity of cathepsin K is unique among mammalian proteinases J. Biol. Chem. 273 1998 32347 32352
17. B.D. Gelb, G.P. Shi, H.A. Chapman, and R.J. Desnick Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency Science 273 1996 1236 1238
18. T. Goto, T. Kiyoshima, R. Moroi, T. Tsukuba, Y. Nishimura, M. Himeno, K. Yamamoto, and T. Tanaka Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and -electron microscopy Histochemistry 101 1994 33 40
19. T. Goto, T. Yamaza, and T. Tanaka Cathepsins in the osteoclast J. Electron. Microsc. 52 2003 551 558
20. G. Haeusler, I. Walter, M. Helmreich, and M. Egerbacher Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation Calcif. Tissue Int. 76 2005 326 335
21. W.S. Hou, D. Brömme, Y. Zhao, E. Mehler, C. Dushey, H. Weinstein, C.S. Miranda, C. Fraga, F. Greig, J. Carey, D.L. Rimoin, R.J. Desnick, and B.D. Gelb Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis J. Clin. Invest. 103 1999 731 738
22. M.K. Houseweart, L.A. Pennacchio, A. Vilaythong, C. Peters, J.L. Noebels, and R.M. Myers Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1) J. Neurobiol. 56 2003 315 327
23. Y. Hu, J. Nyman, P. Muhonen, H.K. Väänänen, and T. Laitala-Leinonen Inhibition of the osteoclast V-ATPase by small interfering RNAs FEBS Lett. 579 2005 4937 4942
24. T. Inui, O. Ishibashi, T. Inaoka, Y. Origane, M. Kumegawa, T. Kokubo, and T. Yamamura Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption J. Biol. Chem. 272 1997 8109 8112
25. K. Isahara, Y. Ohsawa, S. Kanamori, M. Shibata, S. Waguri, N. Sato, T. Gotow, T. Watanabe, T. Momoi, K. Urase, E. Kominami, and Y. Uchiyama Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases Neuroscience 91 1999 233 249
26. O. Ishibashi, T. Inui, Y. Mori, T. Kurokawa, T. Kokubo, and M. Kumegawa Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR Calcif. Tissue Int. 68 2001 109 116
27. M. Järvinen, and A. Rinne Human spleen cysteine proteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants Biochim. Biophys. Acta 708 1982 210 217
28. M. Järvinen, and V.K. Hopsu-Havu Alpha-N-benzoylarginine-2- naphthylamide hydrolase (cathepsin B1 ?) from rat skin. II. Purification of the enzyme and demonstration of two inhibitors in the skin Acta Chem. Scand. 29 1975 772 780
29. T. Kato, T. Takai, K. Mitsuishi, K. Okumura, and H. Ogawa Cystatin A inhibits IL-8 production by keratinocytes stimulated with Der p 1 and Der f 1: biochemical skin barrier against mite cysteine proteases J. Allergy Clin. Immunol. 116 2005 169 176
30. R. Kiviranta, J. Morko, S.L. Alatalo, R. NicAmhlaoibh, J. Risteli, T. Laitala-Leinonen, and E. Vuorio Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL / OPG ratio Bone 36 2005 159 172
31. Z. Kolar, M. Järvinen, and R. Negrini Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1 Neoplasma 36 1989 185 189
32. E. Kominami, Y. Bando, N. Wakamatsu, and N. Katunuma Different tissue distributions of two types of thiol proteinase inhibitors from rat liver and epidermis J. Biochem. (Tokyo) 96 1984 1437 1442
33. P. Lakkakorpi, J. Tuukkanen, T. Hentunen, K. Järvelin, and K. Väänänen Organization of osteoclast microfilaments during the attachment to bone surface in vitro J. Bone Miner. Res. 4 1989 817 825
34. P.T. Lakkakorpi, and H.K. Väänänen Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro J. Bone Miner. Res. 6 1991 817 826
35. E.R. Lee, L. Lamplugh, N.L. Shepard, and J.S. Mort The septoclast, a cathepsin B-rich cell involved in the resorption of growth plate cartilage J. Histochem. Cytochem. 43 1995 525 536
36. U.H. Lerner, L. Johansson, M. Ranjsö, J.B. Rosenquist, F.P. Reinholt, and A. Grubb Cystatin C, and inhibitor of bone resorption produced by osteoblasts Acta Physiol. Scand. 161 1998 81 92
37. K. Lieuallen, L.A. Pennacchio, M. Park, R.M. Myers, and G.G. Lennon Cystatin B-deficient mice have increased expression of apoptosis and glial activation genes Hum. Mol. Genet. 10 2001 1867 1871
38. R. Moroi, T. Yamaza, T. Nishiura, Y. Nishimura, Y. Terada, K. Abe, M. Himeno, and T. Tanaka Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo Arch. Oral Biol. 42 1997 305 315
39. M.T. Mulari, H. Zhao, P.T. Lakkakorpi, and H.K. Väänänen Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake Traffic 4 2003 113 125
40. H. Nakagawa, M. Takami, N. Udagawa, Y. Sawae, K. Suda, T. Sasaki, N. Takahashi, M. Wachi, K. Nagai, and J.T. Woo Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts Bone 33 2003 443 455
41. Y. Ohsawa, T. Nitatori, S. Higuchi, E. Kominami, and Y. Uchiyama Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-beta, in rat osteoclasts J. Histochem. Cytochem. 41 1993 1075 1083
42. V. Parikka, P. Lehenkari, M.L. Sassi, J. Halleen, J. Risteli, P. Härkönen, and H.K. Väänänen Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts Endocrinology 142 2001 5371 5378
43. L.A. Pennacchio, A.E. Lehesjoki, N.E. Stone, V.L. Willour, K. Virtaneva, J. Miao, E. D'Amato, L. Ramirez, M. Faham, M. Koskiniemi, J.A. Warrington, R. Norio, A. de la Chapelle, D.R. Cox, and R.M. Myers Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science 271 1996 1731 1734
44. L.A. Pennacchio, D.M. Bouley, K.M. Higgins, M.P. Scott, J.L. Noebels, and R.M. Myers Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice Nat. Genet. 20 1998 251 258
45. E. Pol, and I. Björk Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases Protein Sci. 10 2001 1729 1738
46. D.P. Rice, H.J. Kim, and I. Thesleff Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development Bone 21 1997 479 486
47. A. Rinne, M. Järvinen, J. Martikainen, M. Alavaikko, and O. Räsänen Über das Vorkommen des epidermalen SH-protease-inhibitors im lymphatischen Gewebe Verh. Anat. Ges. 75 1981 537 574
48. A. Rinne, M. Järvinen, and O. Räsänen A protein reminiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat Acta Histochem. 63 1978 183 192
49. R. Rinne, M. Järvinen, A. Rinne, V.K. Hopsu-Havu, and E. Hokkanen Purification and some characteristics of a cysteine proteinase inhibitor of the human striated muscle Proc. 25th Scand. Congr. Neurol. 69 Suppl 98 1984 220 221
50. R. Rinne, P. Saukko, M. Järvinen, and A.E. Lehesjoki Reduced cystatin B activity correlates with enhanced cathepsin activity in progressive myoclonus epilepsy Ann. Med. 34 2002 380 385
51. J. Robichaud, R. Oballa, P. Prasit, J.P. Falgueyret, M.D. Percival, G. Wesolowski, S.B. Rodan, D. Kimmel, C. Johnson, C. Bryant, S. Venkatraman, E. Setti, R. Mendonca, and J.T. Palmer A novel class of nonpeptidic biaryl inhibitors of human cathepsin K J. Med. Chem. 46 2003 3709 3727
52. P. Saftig, E. Hunziker, O. Wehmeyer, S. Jones, A. Boyde, W. Rommerskirch, J.D. Moritz, P. Schu, and K. von Figura Impaired osteoclastic bone resorption leads to osteoporosis in cathepsin-K-deficient mice Proc. Natl. Acad. Sci. 95 1998 13453 13458
53. J. Salo, P. Lehenkari, M. Mulari, K. Metsikko, and H.K. Väänänen Removal of osteoclast bone resorption products by transcytosis Science 276 1997 270 273
54. K.S. Selander, P.L. Härkönen, E. Valve, J. Mönkkönen, R. Hannuniemi, and H.K. Väänänen Calcitonin promotes osteoclast survival in vitro Mol. Cell Endocrinol. 122 1996 119 129
55. K. Selander, P. Lehenkari, and H.K. Väänänen The effects of bisphosphonates on the resorption cycle of isolated osteoclasts Calcif. Tissue Int. 55 1994 368 375
56. S. Shorey, J.N. Heersche, and M.F. Manolson The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula Bone 35 2004 909 917
57. G.B. Stroup, M.W. Lark, D.F. Veber, A. Bhattacharyya, S. Blake, L.C. Dare, K.F. Erhard, S.J. Hoffman, I.E. James, R.W. Marquis, Y. Ru, J.A. Vasko-Moser, B.R. Smith, T. Tomaszek, and M. Gowen Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate J. Bone Miner. Res. 16 2001 1739 1746
58. K. Sundquist, P. Lakkakorpi, B. Wallmark, and K. Väänänen Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption Biochem. Biophys. Res. Commun. 168 1990 309 313
59. M. Takami, K. Suda, T. Sahara, K. Itoh, K. Nagai, T. Sasaki, N. Udagawa, and N. Takahashi Involvement of vacuolar H+-ATPase in incorporation of risedronate into osteoclasts Bone 32 2003 341 349
60. H. Uusitalo, A. Hiltunen, M. Söderström, H.T. Aro, and E. Vuorio Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus Calcif. Tissue Int. 67 2000 382 390
61. H.K. Väänänen, E.K. Karhukorpi, K. Sundquist, B. Wallmark, I. Roininen, T. Hentunen, J. Tuukkanen, and P. Lakkakorpi Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts J. Cell Biol. 111 1990 1305 1311
62. J. Vääräniemi, J.M. Halleen, K. Kaarlonen, H. Ylipahkala, S.L. Alatalo, G. Andersson, H. Kaija, P. Vihko, and H.K. Väänänen Intracellular machinery for matrix degradation in bone-resorbing osteoclasts J. Bone Miner. Res. 19 2004 1432 1440
63. M. van Eijk, and C. de Groot Germinal center B cell apoptosis requires both caspase and cathepsin activity J. Immunol. 163 1999 2478 2482
64. B. Vray, S. Hartmann, and J. Hoebeke Immunomodulatory properties of cystatins Cell Mol. Life Sci. 59 2002 1503 1512
65. L. Xia, J. Kilb, H. Wex, Z. Li, A. Lipyansky, V. Breuil, L. Stein, J.T. Palmer, D.W. Dempster, and D. Brömme Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones Biol. Chem. 380 1999 679 687
66. T. Yamaza, Y. Tsuji, T. Goto, M.A. Kido, K. Nishijima, R. Moroi, A. Akamine, and T. Tanaka Comparison in localization between cystatin C and cathepsin K in osteoclasts and other cells in mouse tibia epiphysis by immunolight and immunoelectron microscopy Bone 29 2001 42 53
67. X. Yu, Y. Huang, P. Collin-Osdoby, and P. Osdoby Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration J. Bone Miner. Res. 18 2003 1404 1418